This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

14 Feb 2012

Sanofi Posts 4Q 2011 Results

French drugmaker Sanofi has reported a 13 percent rise in fourth-quarter profit.

French drugmaker Sanofi has reported its financial results for the fourth-quarter 2011.


In the quarter pharmaceutical sales were $9.3 billion (+11%), which includes the contribution of $1.1 billion from Genzyme, as well as the impact of generic competition to Lovenox (-13%), Ambien CR (-14%), Taxotere (-68%). For the year pharmaceuticals sales were $36.1 billion, up 7%. Vaccines sales were up 7% (excluding A/H1N1 sales) to $4.5 billion for the year. Diabetes revenue grew 12% in 2011 to $1.6 billion. Genzyme sales (consolidated from April 1, 2011) increased 8% to $3.1 billion for the year. Consumer Health Care and Generics revenue grew 23% to $3.5 billion, and 16% to $2.3 billion, respectively.


4Q Revenues:

Related News